Zepbound leads to more weight loss than Wegovy, Eli Lilly says
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
Which Weight-Loss Drug Is Better: Wegovy or Zepbound?
W ith more people taking the weight-loss drugs Wegovy and Zepbound, one question inevitably arises: which one is more ...
Davis-based Oobli gets FDA's nod for another super-sweet protein to replace sugar
The company's goal is to use sweet proteins to help consumers reduce the amount of carbohydrate sugar in their diets.
Zepbound leads to more weight loss than Wegovy, new study finds
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
BioPharma Dive2 天
Applied’s rare disease drug rejected by FDA
Executives at Applied Therapeutics told analysts they were surprised by the agency’s refusal to approve the company’s ...
Applied Therapeutics: FDA Denial Of Govorestat NDA As Problematic As It Was Unexpected
Applied Therapeutics faces challenges after FDA rejection, but future opportunities exist. Learn why APLT stock could recover ...
Zacks.com on MSN8 天
FDA Begins Review of Alnylam's sNDA for Expanded Amvuttra Use
Alnylam Pharmaceuticals ALNY announced that the FDA has accepted its supplemental new drug application (sNDA) seeking the ...
JD Supra9 天
New Jersey General Assembly Passes Legislation Prohibiting Sale of Diet Pills, Weight Loss ...
1848, which, if it goes into effect, will prohibit the sale or delivery of OTC diet pills, weight loss ... supplements fall with the purview of the law include whether the pill or supplement contains: ...
Drug Store News9 天
Amneal obtains FDA OK for generic Byetta, resubmits DHE NDA
Exenatide is a GLP-1 agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus.
The Best Foods to Eat When Taking Wegovy for Weight Loss
Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...
Amneal Resubmits New Drug Application for Migraine Treatment, Diabetes Drug Is Approved
Amneal Pharmaceuticals resubmitted a new drug application for its migraine treatment to the Food and Drug Administration, and additionally received approval for its diabetes and obesity treatment. The ...
Joplin Globe13 天
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of ...
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist ...